ISG posts strong growth, releases NT-based software

Article

ISG posts strong growth, releases NT-based softwareMedical imaging and PACS software developer ISG Technologies reported strong financial results for its 1998 fiscal third quarter. The company realized a 16% increase in revenue for the period

ISG posts strong growth, releases NT-based software

Medical imaging and PACS software developer ISG Technologies reported strong financial results for its 1998 fiscal third quarter. The company realized a 16% increase in revenue for the period (end-March).

Revenues for the quarter were $9.1 million (Canadian), compared with $7.8 million reported in the same period last year. Net income was $108,000, compared with a net loss of $354,000 in 1997. The firm attributed the quarterly revenue growth to sales of platforms, postprocessing workstation software licenses, and contract engineering activities.

In other ISG news, the Mississauga, Ontario-based company formally released version 3.0 of its VR line of PACS viewing software. ISG demonstrated the Windows NT-based version of the software at the 1997 Radiological Society of North America meeting (PNN 1/98).

Recent Videos
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
Related Content
© 2025 MJH Life Sciences

All rights reserved.